Global Furosemide Injection Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
It is a powerful diuretic, acting on the thick segment of the ascending branch of the myeloid loop.COVID-19 has erupted in the world, and these drugs are in short supply.
LPI (LP Information)' newest research report, the “Furosemide Injection Industry Forecast” looks at past sales and reviews total world Furosemide Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Furosemide Injection sales for 2023 through 2029. With Furosemide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Furosemide Injection industry.
This Insight Report provides a comprehensive analysis of the global Furosemide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Furosemide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Furosemide Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Furosemide Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Furosemide Injection.
The global Furosemide Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Furosemide Injection players cover AuroMedics, Baxter, Fresenius Kabi, Pfizer, Avet Pharmaceuticals, SteriMax, Hunan Kelun Pharmaceutical, Hainan Huanglong Pharm and Shenyang Guagnda Pharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Furosemide Injection market?
What factors are driving Furosemide Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Furosemide Injection market opportunities vary by end market size?
How does Furosemide Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
It is a powerful diuretic, acting on the thick segment of the ascending branch of the myeloid loop.COVID-19 has erupted in the world, and these drugs are in short supply.
LPI (LP Information)' newest research report, the “Furosemide Injection Industry Forecast” looks at past sales and reviews total world Furosemide Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Furosemide Injection sales for 2023 through 2029. With Furosemide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Furosemide Injection industry.
This Insight Report provides a comprehensive analysis of the global Furosemide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Furosemide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Furosemide Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Furosemide Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Furosemide Injection.
The global Furosemide Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Furosemide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Furosemide Injection players cover AuroMedics, Baxter, Fresenius Kabi, Pfizer, Avet Pharmaceuticals, SteriMax, Hunan Kelun Pharmaceutical, Hainan Huanglong Pharm and Shenyang Guagnda Pharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 20mg/2ml
- 40mg/40ml
- 100mg/10ml
- Hospital
- Clinics
- Recovery Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AuroMedics
- Baxter
- Fresenius Kabi
- Pfizer
- Avet Pharmaceuticals
- SteriMax
- Hunan Kelun Pharmaceutical
- Hainan Huanglong Pharm
- Shenyang Guagnda Pharm
- Shagnhai Harvest Pharamceutical
- Chengdu Brilliant Pharmaceutical
- Changbaishan Pharmaceutical
- CSPC Ouyi Pharm
What is the 10-year outlook for the global Furosemide Injection market?
What factors are driving Furosemide Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Furosemide Injection market opportunities vary by end market size?
How does Furosemide Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Furosemide Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Furosemide Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Furosemide Injection by Country/Region, 2018, 2022 & 2029
2.2 Furosemide Injection Segment by Type
2.2.1 20mg/2ml
2.2.2 40mg/40ml
2.2.3 100mg/10ml
2.3 Furosemide Injection Sales by Type
2.3.1 Global Furosemide Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Furosemide Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Furosemide Injection Sale Price by Type (2018-2023)
2.4 Furosemide Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Furosemide Injection Sales by Application
2.5.1 Global Furosemide Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Furosemide Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Furosemide Injection Sale Price by Application (2018-2023)
3 GLOBAL FUROSEMIDE INJECTION BY COMPANY
3.1 Global Furosemide Injection Breakdown Data by Company
3.1.1 Global Furosemide Injection Annual Sales by Company (2018-2023)
3.1.2 Global Furosemide Injection Sales Market Share by Company (2018-2023)
3.2 Global Furosemide Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Furosemide Injection Revenue by Company (2018-2023)
3.2.2 Global Furosemide Injection Revenue Market Share by Company (2018-2023)
3.3 Global Furosemide Injection Sale Price by Company
3.4 Key Manufacturers Furosemide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Furosemide Injection Product Location Distribution
3.4.2 Players Furosemide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FUROSEMIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Furosemide Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Furosemide Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Furosemide Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Furosemide Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Furosemide Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Furosemide Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Furosemide Injection Sales Growth
4.4 APAC Furosemide Injection Sales Growth
4.5 Europe Furosemide Injection Sales Growth
4.6 Middle East & Africa Furosemide Injection Sales Growth
5 AMERICAS
5.1 Americas Furosemide Injection Sales by Country
5.1.1 Americas Furosemide Injection Sales by Country (2018-2023)
5.1.2 Americas Furosemide Injection Revenue by Country (2018-2023)
5.2 Americas Furosemide Injection Sales by Type
5.3 Americas Furosemide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Furosemide Injection Sales by Region
6.1.1 APAC Furosemide Injection Sales by Region (2018-2023)
6.1.2 APAC Furosemide Injection Revenue by Region (2018-2023)
6.2 APAC Furosemide Injection Sales by Type
6.3 APAC Furosemide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Furosemide Injection by Country
7.1.1 Europe Furosemide Injection Sales by Country (2018-2023)
7.1.2 Europe Furosemide Injection Revenue by Country (2018-2023)
7.2 Europe Furosemide Injection Sales by Type
7.3 Europe Furosemide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Furosemide Injection by Country
8.1.1 Middle East & Africa Furosemide Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Furosemide Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Furosemide Injection Sales by Type
8.3 Middle East & Africa Furosemide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Furosemide Injection
10.3 Manufacturing Process Analysis of Furosemide Injection
10.4 Industry Chain Structure of Furosemide Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Furosemide Injection Distributors
11.3 Furosemide Injection Customer
12 WORLD FORECAST REVIEW FOR FUROSEMIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Furosemide Injection Market Size Forecast by Region
12.1.1 Global Furosemide Injection Forecast by Region (2024-2029)
12.1.2 Global Furosemide Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Furosemide Injection Forecast by Type
12.7 Global Furosemide Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AuroMedics
13.1.1 AuroMedics Company Information
13.1.2 AuroMedics Furosemide Injection Product Portfolios and Specifications
13.1.3 AuroMedics Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AuroMedics Main Business Overview
13.1.5 AuroMedics Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Furosemide Injection Product Portfolios and Specifications
13.2.3 Baxter Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Furosemide Injection Product Portfolios and Specifications
13.3.3 Fresenius Kabi Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Furosemide Injection Product Portfolios and Specifications
13.4.3 Pfizer Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Avet Pharmaceuticals
13.5.1 Avet Pharmaceuticals Company Information
13.5.2 Avet Pharmaceuticals Furosemide Injection Product Portfolios and Specifications
13.5.3 Avet Pharmaceuticals Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avet Pharmaceuticals Main Business Overview
13.5.5 Avet Pharmaceuticals Latest Developments
13.6 SteriMax
13.6.1 SteriMax Company Information
13.6.2 SteriMax Furosemide Injection Product Portfolios and Specifications
13.6.3 SteriMax Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SteriMax Main Business Overview
13.6.5 SteriMax Latest Developments
13.7 Hunan Kelun Pharmaceutical
13.7.1 Hunan Kelun Pharmaceutical Company Information
13.7.2 Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.7.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hunan Kelun Pharmaceutical Main Business Overview
13.7.5 Hunan Kelun Pharmaceutical Latest Developments
13.8 Hainan Huanglong Pharm
13.8.1 Hainan Huanglong Pharm Company Information
13.8.2 Hainan Huanglong Pharm Furosemide Injection Product Portfolios and Specifications
13.8.3 Hainan Huanglong Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hainan Huanglong Pharm Main Business Overview
13.8.5 Hainan Huanglong Pharm Latest Developments
13.9 Shenyang Guagnda Pharm
13.9.1 Shenyang Guagnda Pharm Company Information
13.9.2 Shenyang Guagnda Pharm Furosemide Injection Product Portfolios and Specifications
13.9.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shenyang Guagnda Pharm Main Business Overview
13.9.5 Shenyang Guagnda Pharm Latest Developments
13.10 Shagnhai Harvest Pharamceutical
13.10.1 Shagnhai Harvest Pharamceutical Company Information
13.10.2 Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolios and Specifications
13.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shagnhai Harvest Pharamceutical Main Business Overview
13.10.5 Shagnhai Harvest Pharamceutical Latest Developments
13.11 Chengdu Brilliant Pharmaceutical
13.11.1 Chengdu Brilliant Pharmaceutical Company Information
13.11.2 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.11.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Chengdu Brilliant Pharmaceutical Main Business Overview
13.11.5 Chengdu Brilliant Pharmaceutical Latest Developments
13.12 Changbaishan Pharmaceutical
13.12.1 Changbaishan Pharmaceutical Company Information
13.12.2 Changbaishan Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.12.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Changbaishan Pharmaceutical Main Business Overview
13.12.5 Changbaishan Pharmaceutical Latest Developments
13.13 CSPC Ouyi Pharm
13.13.1 CSPC Ouyi Pharm Company Information
13.13.2 CSPC Ouyi Pharm Furosemide Injection Product Portfolios and Specifications
13.13.3 CSPC Ouyi Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CSPC Ouyi Pharm Main Business Overview
13.13.5 CSPC Ouyi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Furosemide Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Furosemide Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Furosemide Injection by Country/Region, 2018, 2022 & 2029
2.2 Furosemide Injection Segment by Type
2.2.1 20mg/2ml
2.2.2 40mg/40ml
2.2.3 100mg/10ml
2.3 Furosemide Injection Sales by Type
2.3.1 Global Furosemide Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Furosemide Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Furosemide Injection Sale Price by Type (2018-2023)
2.4 Furosemide Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Furosemide Injection Sales by Application
2.5.1 Global Furosemide Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Furosemide Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Furosemide Injection Sale Price by Application (2018-2023)
3 GLOBAL FUROSEMIDE INJECTION BY COMPANY
3.1 Global Furosemide Injection Breakdown Data by Company
3.1.1 Global Furosemide Injection Annual Sales by Company (2018-2023)
3.1.2 Global Furosemide Injection Sales Market Share by Company (2018-2023)
3.2 Global Furosemide Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Furosemide Injection Revenue by Company (2018-2023)
3.2.2 Global Furosemide Injection Revenue Market Share by Company (2018-2023)
3.3 Global Furosemide Injection Sale Price by Company
3.4 Key Manufacturers Furosemide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Furosemide Injection Product Location Distribution
3.4.2 Players Furosemide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FUROSEMIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Furosemide Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Furosemide Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Furosemide Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Furosemide Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Furosemide Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Furosemide Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Furosemide Injection Sales Growth
4.4 APAC Furosemide Injection Sales Growth
4.5 Europe Furosemide Injection Sales Growth
4.6 Middle East & Africa Furosemide Injection Sales Growth
5 AMERICAS
5.1 Americas Furosemide Injection Sales by Country
5.1.1 Americas Furosemide Injection Sales by Country (2018-2023)
5.1.2 Americas Furosemide Injection Revenue by Country (2018-2023)
5.2 Americas Furosemide Injection Sales by Type
5.3 Americas Furosemide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Furosemide Injection Sales by Region
6.1.1 APAC Furosemide Injection Sales by Region (2018-2023)
6.1.2 APAC Furosemide Injection Revenue by Region (2018-2023)
6.2 APAC Furosemide Injection Sales by Type
6.3 APAC Furosemide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Furosemide Injection by Country
7.1.1 Europe Furosemide Injection Sales by Country (2018-2023)
7.1.2 Europe Furosemide Injection Revenue by Country (2018-2023)
7.2 Europe Furosemide Injection Sales by Type
7.3 Europe Furosemide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Furosemide Injection by Country
8.1.1 Middle East & Africa Furosemide Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Furosemide Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Furosemide Injection Sales by Type
8.3 Middle East & Africa Furosemide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Furosemide Injection
10.3 Manufacturing Process Analysis of Furosemide Injection
10.4 Industry Chain Structure of Furosemide Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Furosemide Injection Distributors
11.3 Furosemide Injection Customer
12 WORLD FORECAST REVIEW FOR FUROSEMIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Furosemide Injection Market Size Forecast by Region
12.1.1 Global Furosemide Injection Forecast by Region (2024-2029)
12.1.2 Global Furosemide Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Furosemide Injection Forecast by Type
12.7 Global Furosemide Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AuroMedics
13.1.1 AuroMedics Company Information
13.1.2 AuroMedics Furosemide Injection Product Portfolios and Specifications
13.1.3 AuroMedics Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AuroMedics Main Business Overview
13.1.5 AuroMedics Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Furosemide Injection Product Portfolios and Specifications
13.2.3 Baxter Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Furosemide Injection Product Portfolios and Specifications
13.3.3 Fresenius Kabi Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Furosemide Injection Product Portfolios and Specifications
13.4.3 Pfizer Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Avet Pharmaceuticals
13.5.1 Avet Pharmaceuticals Company Information
13.5.2 Avet Pharmaceuticals Furosemide Injection Product Portfolios and Specifications
13.5.3 Avet Pharmaceuticals Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avet Pharmaceuticals Main Business Overview
13.5.5 Avet Pharmaceuticals Latest Developments
13.6 SteriMax
13.6.1 SteriMax Company Information
13.6.2 SteriMax Furosemide Injection Product Portfolios and Specifications
13.6.3 SteriMax Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SteriMax Main Business Overview
13.6.5 SteriMax Latest Developments
13.7 Hunan Kelun Pharmaceutical
13.7.1 Hunan Kelun Pharmaceutical Company Information
13.7.2 Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.7.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hunan Kelun Pharmaceutical Main Business Overview
13.7.5 Hunan Kelun Pharmaceutical Latest Developments
13.8 Hainan Huanglong Pharm
13.8.1 Hainan Huanglong Pharm Company Information
13.8.2 Hainan Huanglong Pharm Furosemide Injection Product Portfolios and Specifications
13.8.3 Hainan Huanglong Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hainan Huanglong Pharm Main Business Overview
13.8.5 Hainan Huanglong Pharm Latest Developments
13.9 Shenyang Guagnda Pharm
13.9.1 Shenyang Guagnda Pharm Company Information
13.9.2 Shenyang Guagnda Pharm Furosemide Injection Product Portfolios and Specifications
13.9.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shenyang Guagnda Pharm Main Business Overview
13.9.5 Shenyang Guagnda Pharm Latest Developments
13.10 Shagnhai Harvest Pharamceutical
13.10.1 Shagnhai Harvest Pharamceutical Company Information
13.10.2 Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolios and Specifications
13.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shagnhai Harvest Pharamceutical Main Business Overview
13.10.5 Shagnhai Harvest Pharamceutical Latest Developments
13.11 Chengdu Brilliant Pharmaceutical
13.11.1 Chengdu Brilliant Pharmaceutical Company Information
13.11.2 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.11.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Chengdu Brilliant Pharmaceutical Main Business Overview
13.11.5 Chengdu Brilliant Pharmaceutical Latest Developments
13.12 Changbaishan Pharmaceutical
13.12.1 Changbaishan Pharmaceutical Company Information
13.12.2 Changbaishan Pharmaceutical Furosemide Injection Product Portfolios and Specifications
13.12.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Changbaishan Pharmaceutical Main Business Overview
13.12.5 Changbaishan Pharmaceutical Latest Developments
13.13 CSPC Ouyi Pharm
13.13.1 CSPC Ouyi Pharm Company Information
13.13.2 CSPC Ouyi Pharm Furosemide Injection Product Portfolios and Specifications
13.13.3 CSPC Ouyi Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CSPC Ouyi Pharm Main Business Overview
13.13.5 CSPC Ouyi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Furosemide Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Furosemide Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 20mg/2ml
Table 4. Major Players of 40mg/40ml
Table 5. Major Players of 100mg/10ml
Table 6. Global Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 7. Global Furosemide Injection Sales Market Share by Type (2018-2023)
Table 8. Global Furosemide Injection Revenue by Type (2018-2023) & ($ million)
Table 9. Global Furosemide Injection Revenue Market Share by Type (2018-2023)
Table 10. Global Furosemide Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 12. Global Furosemide Injection Sales Market Share by Application (2018-2023)
Table 13. Global Furosemide Injection Revenue by Application (2018-2023)
Table 14. Global Furosemide Injection Revenue Market Share by Application (2018-2023)
Table 15. Global Furosemide Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Furosemide Injection Sales by Company (2018-2023) & (K Units)
Table 17. Global Furosemide Injection Sales Market Share by Company (2018-2023)
Table 18. Global Furosemide Injection Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Furosemide Injection Revenue Market Share by Company (2018-2023)
Table 20. Global Furosemide Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Furosemide Injection Producing Area Distribution and Sales Area
Table 22. Players Furosemide Injection Products Offered
Table 23. Furosemide Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Furosemide Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Furosemide Injection Sales Market Share Geographic Region (2018-2023)
Table 28. Global Furosemide Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Furosemide Injection Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Furosemide Injection Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Furosemide Injection Sales Market Share by Country/Region (2018-2023)
Table 32. Global Furosemide Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Furosemide Injection Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 35. Americas Furosemide Injection Sales Market Share by Country (2018-2023)
Table 36. Americas Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 38. Americas Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 39. Americas Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 40. APAC Furosemide Injection Sales by Region (2018-2023) & (K Units)
Table 41. APAC Furosemide Injection Sales Market Share by Region (2018-2023)
Table 42. APAC Furosemide Injection Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Furosemide Injection Revenue Market Share by Region (2018-2023)
Table 44. APAC Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 45. APAC Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 46. Europe Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 47. Europe Furosemide Injection Sales Market Share by Country (2018-2023)
Table 48. Europe Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 50. Europe Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 51. Europe Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Furosemide Injection Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Furosemide Injection
Table 59. Key Market Challenges & Risks of Furosemide Injection
Table 60. Key Industry Trends of Furosemide Injection
Table 61. Furosemide Injection Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Furosemide Injection Distributors List
Table 64. Furosemide Injection Customer List
Table 65. Global Furosemide Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Furosemide Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Furosemide Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Furosemide Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Furosemide Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Furosemide Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Furosemide Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Furosemide Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AuroMedics Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. AuroMedics Furosemide Injection Product Portfolios and Specifications
Table 81. AuroMedics Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. AuroMedics Main Business
Table 83. AuroMedics Latest Developments
Table 84. Baxter Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Baxter Furosemide Injection Product Portfolios and Specifications
Table 86. Baxter Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Baxter Main Business
Table 88. Baxter Latest Developments
Table 89. Fresenius Kabi Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Kabi Furosemide Injection Product Portfolios and Specifications
Table 91. Fresenius Kabi Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Fresenius Kabi Main Business
Table 93. Fresenius Kabi Latest Developments
Table 94. Pfizer Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Furosemide Injection Product Portfolios and Specifications
Table 96. Pfizer Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Avet Pharmaceuticals Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Avet Pharmaceuticals Furosemide Injection Product Portfolios and Specifications
Table 101. Avet Pharmaceuticals Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Avet Pharmaceuticals Main Business
Table 103. Avet Pharmaceuticals Latest Developments
Table 104. SteriMax Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. SteriMax Furosemide Injection Product Portfolios and Specifications
Table 106. SteriMax Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. SteriMax Main Business
Table 108. SteriMax Latest Developments
Table 109. Hunan Kelun Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 111. Hunan Kelun Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Hunan Kelun Pharmaceutical Main Business
Table 113. Hunan Kelun Pharmaceutical Latest Developments
Table 114. Hainan Huanglong Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Hainan Huanglong Pharm Furosemide Injection Product Portfolios and Specifications
Table 116. Hainan Huanglong Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Hainan Huanglong Pharm Main Business
Table 118. Hainan Huanglong Pharm Latest Developments
Table 119. Shenyang Guagnda Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Shenyang Guagnda Pharm Furosemide Injection Product Portfolios and Specifications
Table 121. Shenyang Guagnda Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Shenyang Guagnda Pharm Main Business
Table 123. Shenyang Guagnda Pharm Latest Developments
Table 124. Shagnhai Harvest Pharamceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolios and Specifications
Table 126. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shagnhai Harvest Pharamceutical Main Business
Table 128. Shagnhai Harvest Pharamceutical Latest Developments
Table 129. Chengdu Brilliant Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 131. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Chengdu Brilliant Pharmaceutical Main Business
Table 133. Chengdu Brilliant Pharmaceutical Latest Developments
Table 134. Changbaishan Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. Changbaishan Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 136. Changbaishan Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Changbaishan Pharmaceutical Main Business
Table 138. Changbaishan Pharmaceutical Latest Developments
Table 139. CSPC Ouyi Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. CSPC Ouyi Pharm Furosemide Injection Product Portfolios and Specifications
Table 141. CSPC Ouyi Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. CSPC Ouyi Pharm Main Business
Table 143. CSPC Ouyi Pharm Latest Developments
Table 1. Furosemide Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Furosemide Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 20mg/2ml
Table 4. Major Players of 40mg/40ml
Table 5. Major Players of 100mg/10ml
Table 6. Global Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 7. Global Furosemide Injection Sales Market Share by Type (2018-2023)
Table 8. Global Furosemide Injection Revenue by Type (2018-2023) & ($ million)
Table 9. Global Furosemide Injection Revenue Market Share by Type (2018-2023)
Table 10. Global Furosemide Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 12. Global Furosemide Injection Sales Market Share by Application (2018-2023)
Table 13. Global Furosemide Injection Revenue by Application (2018-2023)
Table 14. Global Furosemide Injection Revenue Market Share by Application (2018-2023)
Table 15. Global Furosemide Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Furosemide Injection Sales by Company (2018-2023) & (K Units)
Table 17. Global Furosemide Injection Sales Market Share by Company (2018-2023)
Table 18. Global Furosemide Injection Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Furosemide Injection Revenue Market Share by Company (2018-2023)
Table 20. Global Furosemide Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Furosemide Injection Producing Area Distribution and Sales Area
Table 22. Players Furosemide Injection Products Offered
Table 23. Furosemide Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Furosemide Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Furosemide Injection Sales Market Share Geographic Region (2018-2023)
Table 28. Global Furosemide Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Furosemide Injection Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Furosemide Injection Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Furosemide Injection Sales Market Share by Country/Region (2018-2023)
Table 32. Global Furosemide Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Furosemide Injection Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 35. Americas Furosemide Injection Sales Market Share by Country (2018-2023)
Table 36. Americas Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 38. Americas Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 39. Americas Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 40. APAC Furosemide Injection Sales by Region (2018-2023) & (K Units)
Table 41. APAC Furosemide Injection Sales Market Share by Region (2018-2023)
Table 42. APAC Furosemide Injection Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Furosemide Injection Revenue Market Share by Region (2018-2023)
Table 44. APAC Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 45. APAC Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 46. Europe Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 47. Europe Furosemide Injection Sales Market Share by Country (2018-2023)
Table 48. Europe Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 50. Europe Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 51. Europe Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Furosemide Injection Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Furosemide Injection Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Furosemide Injection Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Furosemide Injection Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Furosemide Injection Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Furosemide Injection Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Furosemide Injection
Table 59. Key Market Challenges & Risks of Furosemide Injection
Table 60. Key Industry Trends of Furosemide Injection
Table 61. Furosemide Injection Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Furosemide Injection Distributors List
Table 64. Furosemide Injection Customer List
Table 65. Global Furosemide Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Furosemide Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Furosemide Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Furosemide Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Furosemide Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Furosemide Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Furosemide Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Furosemide Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Furosemide Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Furosemide Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AuroMedics Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. AuroMedics Furosemide Injection Product Portfolios and Specifications
Table 81. AuroMedics Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. AuroMedics Main Business
Table 83. AuroMedics Latest Developments
Table 84. Baxter Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Baxter Furosemide Injection Product Portfolios and Specifications
Table 86. Baxter Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Baxter Main Business
Table 88. Baxter Latest Developments
Table 89. Fresenius Kabi Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Kabi Furosemide Injection Product Portfolios and Specifications
Table 91. Fresenius Kabi Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Fresenius Kabi Main Business
Table 93. Fresenius Kabi Latest Developments
Table 94. Pfizer Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Furosemide Injection Product Portfolios and Specifications
Table 96. Pfizer Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Avet Pharmaceuticals Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Avet Pharmaceuticals Furosemide Injection Product Portfolios and Specifications
Table 101. Avet Pharmaceuticals Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Avet Pharmaceuticals Main Business
Table 103. Avet Pharmaceuticals Latest Developments
Table 104. SteriMax Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. SteriMax Furosemide Injection Product Portfolios and Specifications
Table 106. SteriMax Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. SteriMax Main Business
Table 108. SteriMax Latest Developments
Table 109. Hunan Kelun Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 111. Hunan Kelun Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Hunan Kelun Pharmaceutical Main Business
Table 113. Hunan Kelun Pharmaceutical Latest Developments
Table 114. Hainan Huanglong Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Hainan Huanglong Pharm Furosemide Injection Product Portfolios and Specifications
Table 116. Hainan Huanglong Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Hainan Huanglong Pharm Main Business
Table 118. Hainan Huanglong Pharm Latest Developments
Table 119. Shenyang Guagnda Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Shenyang Guagnda Pharm Furosemide Injection Product Portfolios and Specifications
Table 121. Shenyang Guagnda Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Shenyang Guagnda Pharm Main Business
Table 123. Shenyang Guagnda Pharm Latest Developments
Table 124. Shagnhai Harvest Pharamceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolios and Specifications
Table 126. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shagnhai Harvest Pharamceutical Main Business
Table 128. Shagnhai Harvest Pharamceutical Latest Developments
Table 129. Chengdu Brilliant Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 131. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Chengdu Brilliant Pharmaceutical Main Business
Table 133. Chengdu Brilliant Pharmaceutical Latest Developments
Table 134. Changbaishan Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. Changbaishan Pharmaceutical Furosemide Injection Product Portfolios and Specifications
Table 136. Changbaishan Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Changbaishan Pharmaceutical Main Business
Table 138. Changbaishan Pharmaceutical Latest Developments
Table 139. CSPC Ouyi Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. CSPC Ouyi Pharm Furosemide Injection Product Portfolios and Specifications
Table 141. CSPC Ouyi Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. CSPC Ouyi Pharm Main Business
Table 143. CSPC Ouyi Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Furosemide Injection
Figure 2. Furosemide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Furosemide Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Furosemide Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 20mg/2ml
Figure 10. Product Picture of 40mg/40ml
Figure 11. Product Picture of 100mg/10ml
Figure 12. Global Furosemide Injection Sales Market Share by Type in 2022
Figure 13. Global Furosemide Injection Revenue Market Share by Type (2018-2023)
Figure 14. Furosemide Injection Consumed in Hospital
Figure 15. Global Furosemide Injection Market: Hospital (2018-2023) & (K Units)
Figure 16. Furosemide Injection Consumed in Clinics
Figure 17. Global Furosemide Injection Market: Clinics (2018-2023) & (K Units)
Figure 18. Furosemide Injection Consumed in Recovery Center
Figure 19. Global Furosemide Injection Market: Recovery Center (2018-2023) & (K Units)
Figure 20. Global Furosemide Injection Sales Market Share by Application (2022)
Figure 21. Global Furosemide Injection Revenue Market Share by Application in 2022
Figure 22. Furosemide Injection Sales Market by Company in 2022 (K Units)
Figure 23. Global Furosemide Injection Sales Market Share by Company in 2022
Figure 24. Furosemide Injection Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Furosemide Injection Revenue Market Share by Company in 2022
Figure 26. Global Furosemide Injection Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Furosemide Injection Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Furosemide Injection Sales 2018-2023 (K Units)
Figure 29. Americas Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 30. APAC Furosemide Injection Sales 2018-2023 (K Units)
Figure 31. APAC Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 32. Europe Furosemide Injection Sales 2018-2023 (K Units)
Figure 33. Europe Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Furosemide Injection Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 36. Americas Furosemide Injection Sales Market Share by Country in 2022
Figure 37. Americas Furosemide Injection Revenue Market Share by Country in 2022
Figure 38. Americas Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 39. Americas Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 40. United States Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Furosemide Injection Sales Market Share by Region in 2022
Figure 45. APAC Furosemide Injection Revenue Market Share by Regions in 2022
Figure 46. APAC Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 47. APAC Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 48. China Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Furosemide Injection Sales Market Share by Country in 2022
Figure 56. Europe Furosemide Injection Revenue Market Share by Country in 2022
Figure 57. Europe Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 58. Europe Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 59. Germany Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Furosemide Injection Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Furosemide Injection Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 68. Egypt Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Furosemide Injection in 2022
Figure 74. Manufacturing Process Analysis of Furosemide Injection
Figure 75. Industry Chain Structure of Furosemide Injection
Figure 76. Channels of Distribution
Figure 77. Global Furosemide Injection Sales Market Forecast by Region (2024-2029)
Figure 78. Global Furosemide Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Furosemide Injection Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Furosemide Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Furosemide Injection Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Furosemide Injection Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Furosemide Injection
Figure 2. Furosemide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Furosemide Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Furosemide Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 20mg/2ml
Figure 10. Product Picture of 40mg/40ml
Figure 11. Product Picture of 100mg/10ml
Figure 12. Global Furosemide Injection Sales Market Share by Type in 2022
Figure 13. Global Furosemide Injection Revenue Market Share by Type (2018-2023)
Figure 14. Furosemide Injection Consumed in Hospital
Figure 15. Global Furosemide Injection Market: Hospital (2018-2023) & (K Units)
Figure 16. Furosemide Injection Consumed in Clinics
Figure 17. Global Furosemide Injection Market: Clinics (2018-2023) & (K Units)
Figure 18. Furosemide Injection Consumed in Recovery Center
Figure 19. Global Furosemide Injection Market: Recovery Center (2018-2023) & (K Units)
Figure 20. Global Furosemide Injection Sales Market Share by Application (2022)
Figure 21. Global Furosemide Injection Revenue Market Share by Application in 2022
Figure 22. Furosemide Injection Sales Market by Company in 2022 (K Units)
Figure 23. Global Furosemide Injection Sales Market Share by Company in 2022
Figure 24. Furosemide Injection Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Furosemide Injection Revenue Market Share by Company in 2022
Figure 26. Global Furosemide Injection Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Furosemide Injection Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Furosemide Injection Sales 2018-2023 (K Units)
Figure 29. Americas Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 30. APAC Furosemide Injection Sales 2018-2023 (K Units)
Figure 31. APAC Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 32. Europe Furosemide Injection Sales 2018-2023 (K Units)
Figure 33. Europe Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Furosemide Injection Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Furosemide Injection Revenue 2018-2023 ($ Millions)
Figure 36. Americas Furosemide Injection Sales Market Share by Country in 2022
Figure 37. Americas Furosemide Injection Revenue Market Share by Country in 2022
Figure 38. Americas Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 39. Americas Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 40. United States Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Furosemide Injection Sales Market Share by Region in 2022
Figure 45. APAC Furosemide Injection Revenue Market Share by Regions in 2022
Figure 46. APAC Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 47. APAC Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 48. China Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Furosemide Injection Sales Market Share by Country in 2022
Figure 56. Europe Furosemide Injection Revenue Market Share by Country in 2022
Figure 57. Europe Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 58. Europe Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 59. Germany Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Furosemide Injection Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Furosemide Injection Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Furosemide Injection Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Furosemide Injection Sales Market Share by Application (2018-2023)
Figure 68. Egypt Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Furosemide Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Furosemide Injection in 2022
Figure 74. Manufacturing Process Analysis of Furosemide Injection
Figure 75. Industry Chain Structure of Furosemide Injection
Figure 76. Channels of Distribution
Figure 77. Global Furosemide Injection Sales Market Forecast by Region (2024-2029)
Figure 78. Global Furosemide Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Furosemide Injection Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Furosemide Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Furosemide Injection Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Furosemide Injection Revenue Market Share Forecast by Application (2024-2029)
